In contrast, the administration of the K409A Hsp65, a point-mutated molecule [17], did not affect SLE evolution or survival; the combined administration of WT and K409A Hsp65 proteins showed that the K409A is able to inhibit but not reverse the effects of WT on F1 mice. This evidence concerns the gene HSPD1 and systemic lupus erythematosus.